www.fdanews.com/articles/187530-thermofishers-allergy-autoimmune-testing-platform-gets-ce-mark
ThermoFisher’s Allergy, AutoImmune Testing Platform Gets CE Mark
July 9, 2018
ThermoFisher’s Phadia 200, a benchtop instrument used to test for allergy and autoimmunity conditions, has received CE Mark approval.
The instrument, which quantifies clinically relevant antibodies in blood, is capable of performing up to 700 different ImmunoCAP and EliA tests. It can process 42 samples and produce up to 200 test results daily.
The device is meant to be used in smaller diagnostic facilities for the purposes of improving output and efficiency, and reduces the frequency of sending samples offsite for testing.